Chunyan Dong

17PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 30, 2026
Targeting the Vim-PGI2 Pathway Enhances CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer.

|Apr 24, 2026
Human Pancreatic Cancer Organoids.

|Oct 08, 2025
Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression.

Lujing Shao, Qianke Xing, Yao Xiong

|Jul 12, 2025
Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 2022, 14, 2101.

Pingting Ye, Lei Feng, Shuo Shi

|Feb 05, 2025
Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib.

Lujing Shao, Tong Li, Xinyan Jia

|Jan 15, 2025
A responsive cocktail nano-strategy breaking the immune excluded state enhances immunotherapy for triple negative breast cancer.

Jingxian Yang, Mengyao Chen, Ruihao Li

Pageof 3

Frequent Collaborators

9 joint publications

Shuo Shi

1 joint publications

Shujing Liang

1 joint publications

Tianming Yao

1 joint publications

Mohamed Nabeel Mattath